All Pathways
Hematology & OncologyEmergency

Neutropenic Enterocolitis (Typhlitis) Management

Neutropenic Enterocolitis (Typhlitis) Management: Suspected Neutropenic Enterocolitis → Recognize Clinical Triad → Identify Risk Factors → Obtain CT Abd...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected Neutropenic Enterocolitis

    Abdominal symptoms in neutropenic patient

    1. Action

      Recognize Clinical Triad

      Classic presentation

      • 1. NEUTROPENIA: ANC <500/μL
      • (often profound <100)
      • 2. FEVER: Temperature ≥38°C
      • 3. ABDOMINAL PAIN:
      • • Right lower quadrant (cecum)
      • • May be diffuse
      • • Cramping, tenderness, distension
      • OTHER: Diarrhea (often bloody), nausea/vomiting
      1. Action

        Identify Risk Factors

        Who develops typhlitis

        • HIGH RISK:
        • • AML induction chemotherapy
        • • High-dose cytarabine
        • • Taxanes (docetaxel, paclitaxel)
        • • HSCT conditioning
        • • Aplastic anemia treatment
        • TIMING: Usually during nadir (7-14 days post-chemo)
        • Incidence: 5-10% in hematologic malignancy
        1. Action

          Obtain CT Abdomen/Pelvis

          Imaging is key to diagnosis

          • CT WITH IV CONTRAST (if renal function allows)
          • DIAGNOSTIC FINDINGS:
          • • Bowel wall thickening ≥4mm
          • • Most common: cecum, ascending colon, terminal ileum
          • • Pericolonic fat stranding
          • • Intramural gas (pneumatosis - severe)
          • • Ascites
          • RULE OUT: Perforation, abscess, appendicitis
          1. Decision

            Assess Severity

            Guides management approach

            • MILD-MODERATE:
            • • Bowel wall 4-10mm
            • • No perforation/abscess
            • • Hemodynamically stable
            • SEVERE:
            • • Bowel wall >10mm
            • • Pneumatosis intestinalis
            • • Perforation or abscess
            • • Septic shock
            • • Peritonitis
            1. Action

              Conservative Management

              Most cases managed medically

              • 1. NPO (bowel rest)
              • 2. NG tube if significant distension/vomiting
              • 3. IV fluids and electrolyte replacement
              • 4. TPN if prolonged bowel rest expected
              • 5. Broad-spectrum antibiotics:
              • • Piperacillin-tazobactam 4.5g IV q6h OR
              • • Meropenem 1g IV q8h
              • • ADD Vancomycin if hemodynamically unstable
              • • ADD Metronidazole for anaerobes
              • 6. G-CSF to shorten neutropenia
              1. Action

                Rule Out C. difficile

                Common coexisting infection

                • C. diff testing on stool (PCR or toxin)
                • May coexist with typhlitis
                • If positive: Add oral vancomycin 125mg QID
                • Avoid antimotility agents
                • Fidaxomicin alternative
                1. Action

                  Close Monitoring

                  Serial assessments

                  • Serial abdominal exams q4-6h
                  • Daily CBC, BMP, lactate
                  • Repeat CT if clinical deterioration
                  • Watch for: increasing distension, peritonitis, shock
                  • Most improve within 5-7 days as ANC recovers
                  1. Decision

                    Surgical Consultation Needed?

                    Indications for surgical intervention

                    • ABSOLUTE INDICATIONS:
                    • • Free perforation with peritonitis
                    • • Uncontrolled GI bleeding
                    • • Clinical deterioration despite medical therapy
                    • RELATIVE INDICATIONS:
                    • • Abscess requiring drainage
                    • • Persistent sepsis despite antibiotics
                    • • Bowel necrosis on imaging
                    • HIGH MORTALITY: Surgery in neutropenic patients ~50%
                    1. Action

                      Surgical Intervention

                      When conservative management fails

                      • Right hemicolectomy most common
                      • Diverting ileostomy may be needed
                      • High morbidity/mortality in neutropenic patients
                      • Delay if possible until ANC recovering
                      • G-CSF perioperatively
                      1. Action

                        Recovery & Diet Advancement

                        As neutropenia resolves

                        • Advance diet slowly as symptoms improve
                        • Clear liquids → low residue → regular
                        • Continue antibiotics until afebrile + ANC >500
                        • Future chemotherapy: consider dose reduction
                        • Recurrence possible with subsequent cycles
                        1. Outcome

                          Typhlitis Resolved

                          Plan for future chemotherapy cycles

Guideline Source

Neutropenic Enterocolitis: Clinical Evidence and Management

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Diagnostic criteria not universally standardized
  • Surgical thresholds vary by institution
  • Limited prospective data on management
  • May be confused with C. diff or other colitides

Applicable Regions

USEU
Version 1Next review: 2027-01-11

Frequently Asked Questions

What is the Neutropenic Enterocolitis (Typhlitis) Management?

The Neutropenic Enterocolitis (Typhlitis) Management is a emergency clinical algorithm for Hematology & Oncology. It provides a structured decision tree to guide clinical decision-making, based on Neutropenic Enterocolitis: Clinical Evidence and Management.

What guideline is the Neutropenic Enterocolitis (Typhlitis) Management based on?

This algorithm is based on Neutropenic Enterocolitis: Clinical Evidence and Management (DOI: 10.1148/rg.2019180097).

What are the limitations of the Neutropenic Enterocolitis (Typhlitis) Management?

Known limitations include: Diagnostic criteria not universally standardized; Surgical thresholds vary by institution; Limited prospective data on management; May be confused with C. diff or other colitides. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Neutropenic Enterocolitis (Typhlitis) Management appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free